FDA: FDA Decision Memorandum - Tirzepatide Injection Shortage (Dec 19, 2024)

FDA: FDA Decision Memorandum - Tirzepatide Injection Shortage (Dec 19, 2024)

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
Request Content: FDA Decision Memorandum: “Resolution of Tirzepatide Injection Product Shortage and Supply Status,” dated December 19, 2024.
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details